Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.50
Dec. 20, 2024 16:00:00- Change 0.11 (4.6025%)
- Volume 34,720
- Today's Open 2.36
- Previous Close 2.39
- Today's High 2.55
- Today's Low 2.36
- 52 Week High 3.43
- 52 Week Low 1.57